Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 1997

View Archived Issues

Naratriptan highlighted at headache congress; introduced in U.K.

Novel melatonergic agents described by Bristol-Myers Squibb

Encouraging data reported for Sugen's insulin phosphatase inhibitors

Kyowa Hakko claims compounds for thrombocytopenia

FDA advisory committee withholds recommendation of Ilex Oncology's treatment for AIDS-related NHL

Ono describes elastase inhibitors

P&U prepares inhibitors of kynurenine 3-hydroxylase for neurodegenerative diseases

U.S. patents issued to Yale University and Innovir for EGS technology

Selective dopamine D3 receptor ligands from Novo Nordisk

MS&D prepares potent and selective 5-HT1D agonists

Neurogen and Tularik sign drug discovery agreement

Protein farnesyltransferase inhibitors from Janssen

Megabios issued patent for aerosol gene delivery system

Efficacy of SB-206284A in animal models of cerebral ischemia

Positive efficacy profile for MacroChem's erectile dysfunction therapy

Univ. of Tokyo scientists isolate potent and selective papain inhibitor

Abbott selects new motilide as candidate for GI motility disorders

Potential new antidiabetic and antiobesity agent from Dainippon

Case report of congenital abnormalities associated with maternal methotrexate ingestion

Valaciclovir vs. placebo for recurrent genital HSV

NMDA antagonists improve memory deficits after brain injury in the rat

Hypolipidemic effects of F-1394 in hyperlipidemic dogs

Antipruritogenic effect of Kochia Fructus extract and active components

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...